| 1 |
34130445 | Efficacy and Safety of Self-Titration Algorithms of Insulin Glargine 300 units/mL in Individuals with Uncontrolled Type 2 Diabetes Mellitus (The Korean TITRATION Study): A Randomized Controlled Trial. | 2022 Jan |
4 |
| 2 |
34514696 | Switching the basal insulin to insulin glargine 300 U/ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety. | 2022 Jan |
1 |
| 3 |
34530162 | Far-red light-activated human islet-like designer cells enable sustained fine-tuned secretion of insulin for glucose control. | 2022 Jan 5 |
1 |
| 4 |
34551215 | Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 diabetes. | 2022 Mar |
1 |
| 5 |
34643020 | Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial. | 2022 Feb |
2 |
| 6 |
34716211 | Traveling Across Time Zones With Type 1 Diabetes: A Pilot Study Comparing Insulin Degludec With Insulin Glargine U100. | 2022 Jan 1 |
1 |
| 7 |
34728531 | Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin: Results of an Open-label Randomized Parallel-Design Trial. | 2022 Jan 1 |
1 |
| 8 |
34784005 | Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis. | 2022 Jan |
1 |
| 9 |
34866291 | Glycaemic variability in patients with type 2 diabetes mellitus treated with dulaglutide, with and without concomitant insulin: Post hoc analyses of randomized clinical trials. | 2022 Apr |
3 |
| 10 |
35014145 | Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT). | 2022 May |
1 |
| 11 |
35141727 | The Comparative Dosing and Glycemic Control of Intermediate and Long-Acting Insulins in Adult Patients With Type 1 and 2 Diabetes Mellitus. | 2022 Feb |
2 |
| 12 |
35171918 | Comparison of the effects of empagliflozin and glimepiride on endothelial function in patients with type 2 diabetes: A randomized controlled study. | 2022 |
1 |
| 13 |
35187770 | Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus. | 2022 Jun |
1 |
| 14 |
35239165 | Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION Study. | 2022 Mar |
1 |
| 15 |
35372263 | Synthesis and Characterization of Phenylboronic Acid-Modified Insulin With Glucose-Dependent Solubility. | 2022 |
1 |
| 16 |
35410614 | Assessment of the Effect of Timing of Insulin Glargine Administration (bedtime versus morning) on Glycemic Control in Children with Type 1 Diabetes in Cairo, Egypt: A Single Centre Experience. | 2022 Apr 11 |
1 |
| 17 |
35431280 | Comparative efficiency and safety of insulin degludec/aspart with insulin glargine in type 2 diabetes: a meta-analysis of randomized controlled trials. | 2022 Apr 15 |
1 |
| 18 |
35463857 | Production of insulin antibody associated with relapsed hodgkin's lymphoma. | 2022 Apr |
1 |
| 19 |
35467938 | Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia. | 2022 Jun 22 |
2 |
| 20 |
35471721 | Efficacy and Safety of LY2963016 Insulin Glargine in Chinese Patients with Type 1 Diabetes Previously Treated with Insulin Glargine (Lantus®): a Post Hoc Analysis of a Randomized, Open-Label, Phase 3 Trial. | 2022 Jun |
1 |
| 21 |
35532858 | Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naïve People with Type 2 Diabetes: the ATOS Study. | 2022 Jun |
1 |
| 22 |
35579011 | Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis. | 2022 May 25 |
3 |
| 23 |
35600866 | Electronic Health Records to Rapidly Assess Biosimilar Uptake: An Example Using Insulin Glargine in a Large U.S. Nursing Home Cohort. | 2022 |
4 |
| 24 |
31280640 | Impact of Dosing Conversion From Basal Insulin to Follow-On Insulin Glargine. | 2021 Apr |
2 |
| 25 |
32991041 | Gastrointestinal adverse events with insulin glargine/lixisenatide fixed-ratio combination versus glucagon-like peptide-1 receptor agonists in people with type 2 diabetes mellitus: A network meta-analysis. | 2021 Jan |
1 |
| 26 |
33131992 | Glargine insulin loaded lipid nanoparticles: Oral delivery of liquid and solid oral dosage forms. | 2021 Feb 8 |
4 |
| 27 |
33201346 | Correction to: Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus®) and Lantus® in healthy subjects: a double-blind, randomized clamp study. | 2021 Jan |
1 |
| 28 |
33251697 | Metabolic and sympathovagal effects of bolus insulin glulisine versus basal insulin glargine therapy in people with type 2 diabetes: A randomized controlled study. | 2021 Jul |
1 |
| 29 |
33307335 | Comparison of pharmacodynamics between insulin glargine 100 U/mL and insulin glargine 300 U/mL in healthy cats. | 2021 Apr |
3 |
| 30 |
33315628 | Advances in newer basal and bolus insulins: impact on type 1 diabetes. | 2021 Feb 1 |
2 |
| 31 |
33317342 | Needle-free jet injection of insulin glargine improves glycemic control in patients with type 2 diabetes mellitus: a study based on the flash glucose monitoring system. | 2021 May |
3 |
| 32 |
33354715 | Weight gain associated with insulin detemir vs insulin glargine in clinical practice: A retrospective longitudinal cohort study. | 2021 Feb 19 |
4 |
| 33 |
33469328 | Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes. | 2021 |
2 |
| 34 |
33501891 | Insulin acutely increases agonist-induced airway smooth muscle contraction in humans and rats. | 2021 Apr 1 |
1 |
| 35 |
33512347 | In Brief: Semglee - a new insulin glargine for diabetes. | 2021 Jan 25 |
1 |
| 36 |
33540243 | Use of insulin glargine during pregnancy: A review. | 2021 Jan-Feb |
7 |
| 37 |
33569407 | Effectiveness and safety of insulin glargine Gla-300 in insulin-naïve type 2 diabetes subjects in a real-life setting-the GOAL_RO trial. | 2021 Jan |
1 |
| 38 |
33592769 | Development and validation of a method for quantification of human insulin and its synthetic analogues in plasma and post-mortem sera by LC-MS/HRMS. | 2021 Apr 1 |
1 |
| 39 |
33604804 | Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study. | 2021 Mar |
2 |
| 40 |
33655870 | Evaluation of Early Administration of Insulin Glargine in the Acute Management of Diabetic Ketoacidosis. | 2021 |
5 |
| 41 |
33662147 | (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus. | 2021 Mar 4 |
3 |
| 42 |
33675117 | Efficacy and safety of dulaglutide compared with glargine in patients with type 2 diabetes: A systematic review and meta-analysis. | 2021 Oct |
1 |
| 43 |
33721211 | All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK. | 2021 May |
3 |
| 44 |
33734004 | Ongoing efforts to improve the management of patients with diabetes in Bangladesh and the implications. | 2021 Oct |
1 |
| 45 |
33738774 | Glycemic Variability and Time in Range During Self-titration of Once Daily Insulin Glargine 300 U/ml Versus Neutral Protamine Hagedorn Insulin in Insulin-naïve Chinese Type 2 Diabetes Patients. | 2021 May |
2 |
| 46 |
33751403 | Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis. | 2021 Apr |
1 |
| 47 |
33786271 | Basal insulin ameliorates post-breakfast hyperglycemia via suppression of post-breakfast proinsulin/C-peptide ratio and fasting serum free fatty acid levels in patients with type 2 diabetes. | 2021 Apr |
1 |
| 48 |
33790599 | Efficacy and Safety of a Decision Support Intervention for Basal Insulin Self-Titration Assisted by the Nurse in Outpatients with T2DM: A Randomized Controlled Trial. | 2021 |
1 |
| 49 |
33843291 | Inpatient Insulin Pen Implementation, Waste, and Potential Cost Savings: A Community Hospital Experience. | 2021 Jul |
1 |
| 50 |
33845056 | Morphologic design of sugar-based polymer nanoparticles for delivery of antidiabetic peptides. | 2021 Jun 10 |
8 |